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top broadcause non-communicable 
disease groups and health systems 
generally. We are at a crucial point 
in time when the burden from 
musculoskeletal diseases and other 
non-communicable diseases can be 
mitigated, but urgent action is needed. 
Pearce and colleagues1 make important 
and sensible recommendations for this 
through inclusion in strategies such as 
the 25×25 strategy.
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25×25 strategy for the 
burden of non-
communicable diseases
We congratulate Neil Pearce and col-
leagues on their Comment about the 
25×25 strategy.1 This strategy is a global 
target of a 25% relative reduction in 
mortality from non-communicable 
diseases by the year 2025. Global policy 
should be updated to show the current 
and future global health scenario with 
inclusion of non-communicable diseases 
that reach beyond the traditional top 
broad-cause groups (ie, cardiovascular 
disease, stroke, chronic lung diseases, 
cancer, and diabetes), and which also 
take into account non-fatal burden.
More than anywhere, this issue is 
crucial for low-income and middle-
income countries where in the 
recent Global Burden of Disease 
study, 2010,2 in terms of broadcause 
non-communicable disease groups, 
mental and behavioural disorders and 
musculoskeletal disease rank in the 
top four groups (table). In the case 
of musculoskeletal diseases, of all 
291 conditions, three of the top ten 
disorders in developing countries, in 
terms of both burden and disability, 
were musculoskeletal disorders. Good 
musculoskeletal health and mobility 
is fundamental for the prevention of 
other non-communicable diseases 
and essential for independent and 
productive lives at all ages. Musculo-
skeletal problems are common 
co morbidities with other non-com-
municable diseases, and this com-
bination further reduces function, 
and impedes eﬀ orts to prevent further 
damage (eg, eﬀ orts such as increased 
physical activity).3,4 
Many opportunities exist for global 
health policy and programmes to 
include and address the burden of 
non-communicable diseases beyond 
the traditional broadcause groups. 
Research is needed on how to best deal 
with all non-communicable diseases 
in a way that addresses the broader 
determinants, adheres to principles 
of development effectiveness,5 and 
explores and promotes collaboration 
and integration with work that is 
already being done on the traditional 
Burden (million DALYs)
Cardiovascular and circulatory diseases 214
Mental and behavioural disorders 141
Cancers 130
Musculoskeletal diseases 119
Chronic respiratory diseases 101
Diabetes, urogenital, blood, and endocrine diseases 99
Neurological disorders 57
Digestive disorders (except cirrhosis) 27
Cirrhosis of the liver 25
Other NCDs broadcause group 107
Total 1020 
NCD=non-communicable disease. DALY=disability-adjusted life years.
Table: Burden from NCDs in low-income and middle-income countries, Global Burden of Disease, 20102
